Augmedix, Inc. (NASDAQ:AUGX) Q4 2022 Earnings Conference Call March 27, 2023 8:00 AM ET

Company Participants

Matt Chesler - Investor Relations

Manny Krakaris - Chief Executive Officer

Paul Ginocchio - Chief Financial Officer

Conference Call Participants

Jared Hasson - William Blair

Neil Chatterji - B. Riley Securities

Allen Klee - Maxim Group

Operator

Greetings, welcome to Augmedix Incorporated 2022 Fourth Quarter Earnings Conference Call. At this time, all participants will be in listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded.

At this time, I'll now turn the conference over to Matt Chesler from Investor Relations. Matt, you may now begin.

Matt Chesler

Thank you, and thank you all for participating in today’s call. Joining me are Manny Krakaris, Chief Executive Officer; and Paul Ginocchio, Chief Financial Officer. Earlier this morning, Augmedix released financial results for the quarter ended December 31, 2022. A copy of the press release is available on the company’s website.

Before we begin, I’d like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results or performance, are forward-looking statements.

These forward-looking statements are based upon current estimates and various assumptions and involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements. For a list and description of the risks and uncertainties associated with our business, please refer to the risk factors and management discussion and analysis of financial condition and results of operations in our most recent Form 10-K and Form 10-Q filed with the Securities and Exchange Commission, and similar disclosures and subsequent reports filed with the SEC.

Also during our call today, we may discuss non-GAAP financial measures, which adjust our GAAP results to eliminate the impact certain items. You will find additional information regarding these non-GAAP financial measures and a reconciliation of these non-GAAP to GAAP measures in today’s financial results press release.

This conference call contains time sensitive information and is accurate only as of the live broadcast today, March 27, 2023. Augmedix disclaims any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events or otherwise.